Polymorphisms related to the serum 25-hydroxyvitamin D level and risk of myocardial infarction, diabetes, cancer and mortality. The Tromsø Study.

Polymorphisms related to the serum 25-hydroxyvitamin D level and risk of myocardial infarction, diabetes, cancer and mortality. The Tromsø Study.

Low serum 25(OH)D levels are associated with cardiovascular risk factors, and also predict future myocardial infarction (MI), type 2 diabetes (T2DM), cancer and all-cause mortality. Recently several single nucleotide polymorphisms (SNPs) associated with serum 25-hydroxyvitamin D (25(OH)D) level have...

Full description

Bibliographic Details
Main Authors: Rolf Jorde, Henrik Schirmer, Tom Wilsgaard, Ragnar Martin Joakimsen, Ellisiv Bøgeberg Mathiesen, Inger Njølstad, Maja-Lisa Løchen, Yngve Figenschau, Jens Petter Berg, Johan Svartberg, Guri Grimnes
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3359337?pdf=render

Internet

http://europepmc.org/articles/PMC3359337?pdf=render

Similar Items